Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sagar Lonial

Showing results (11-20 of 440) with videos related to

Pageof 44
Sort By:
Hematology. American Society of Hematology. Education Program|January 18, 2011
Relapsed multiple myelomaSagar Lonial
Clinical Advances in Hematology & Oncology : H&O|June 17, 2010
Frontline regimens for multiple myeloma patientsSagar Lonial
Blood|August 21, 2010
The White House crusade against ... MGUS?Sagar Lonial
Clinical Advances in Hematology & Oncology : H&O|November 6, 2007
Complete remission of multiple myelomaSagar Lonial
Clinical Advances in Hematology & Oncology : H&O|January 13, 2023
Optimizing the benefits of BCMA-targeted CAR T-cell therapy in multiple myelomaSagar Lonial
Blood|October 19, 2013
"A fortuitous combination of circumstances"Sagar Lonial
Clinical Advances in Hematology & Oncology : H&O|September 22, 2025
Is there a universal standard of care for frontline therapy in multiple myeloma?Sagar Lonial
Blood|July 18, 2009
Risky business in myelomaSagar Lonial
Cancer Treatment and Research|October 4, 2016
Treatment of MM: Upcoming Novel TherapiesSagar Lonial
Cancer Journal (Sudbury, Mass.)|February 4, 2016
Monoclonal Antibodies for the Treatment of Myeloma: Targeting SLAMF7 and CD38Sagar Lonial
Pageof 44

Showing results (11-20 of 440) with videos related to

Sort By:
Pageof 44
Hematology. American Society of Hematology. Education Program|January 18, 2011
Relapsed multiple myelomaSagar Lonial
Clinical Advances in Hematology & Oncology : H&O|June 17, 2010
Frontline regimens for multiple myeloma patientsSagar Lonial
Blood|August 21, 2010
The White House crusade against ... MGUS?Sagar Lonial
Clinical Advances in Hematology & Oncology : H&O|November 6, 2007
Complete remission of multiple myelomaSagar Lonial
Clinical Advances in Hematology & Oncology : H&O|January 13, 2023
Optimizing the benefits of BCMA-targeted CAR T-cell therapy in multiple myelomaSagar Lonial
Blood|October 19, 2013
"A fortuitous combination of circumstances"Sagar Lonial
Clinical Advances in Hematology & Oncology : H&O|September 22, 2025
Is there a universal standard of care for frontline therapy in multiple myeloma?Sagar Lonial
Blood|July 18, 2009
Risky business in myelomaSagar Lonial
Cancer Treatment and Research|October 4, 2016
Treatment of MM: Upcoming Novel TherapiesSagar Lonial
Cancer Journal (Sudbury, Mass.)|February 4, 2016
Monoclonal Antibodies for the Treatment of Myeloma: Targeting SLAMF7 and CD38Sagar Lonial
Pageof 44